Inequities are endemic to the US healthcare system and significantly affect our patients living with diabetes. It’s time for change.

We understand the important role primary care professionals play in the lives of individuals with diabetes, particularly in underserved communities. Many people who require complex diabetes management typically receive care from primary care professionals instead of diabetes specialists. This initiative addresses the urgent and persistent needs of vulnerable populations of people with diabetes, in particular targeting those who also have CKD. Through this series, we seek to empower primary care clinicians and increase their capacity to screen, diagnose, and manage renal complications of diabetes using the Project ECHO (Extension for Community Healthcare Outcomes) model.

Each of the 4 sessions will focus on the “ABCDES” needed to improve diabetes care: Access, Beyond A1C, Confidence, Disparities, Education, and Systems. Our hub team of experts is a diverse group of thought leaders from 8 academic institutions across the US and a diabetes advocacy organization who will provide foundational education, case-based mentoring in real time, and a holistic perspective of every opportunity and barrier discussed.

 

At the end of this four part series, the learner should be able to: 

  • Describe evidence- and guideline-based processes for screening for renal disease among patients with type 2 diabetes 
  • Use evidence-based, collaborative strategies to design and implement individualized diabetes management strategies that consider glycemic and nonglycemic targets 
  • Design care plans that incorporate effective patient education and empowerment 

 

Sessions

Approaches to Identifying CKD and the New Kidney Health Evaluation

January 19, 2022

Looking Beyond Glucose Control: Best Practices to Address Diabetes-Related CKD

February 16, 2022

Addressing CKD Disparities and Social Determinants of Health to Achieve Diabetes Management Goals

March 16, 2022

Halting CKD Progression: From Optimizing Hypertension Management to Newer Agents

April 20, 2022